194 related articles for article (PubMed ID: 28780706)
1. Validity, reliability, and sensitivity to change of the myasthenia gravis activities of daily living profile in a sample of Italian myasthenic patients.
Raggi A; Antozzi C; Baggi F; Leonardi M; Maggi L; Mantegazza R
Neurol Sci; 2017 Nov; 38(11):1927-1931. PubMed ID: 28780706
[TBL] [Abstract][Full Text] [Related]
2. Validation of the italian version of the 15-item Myasthenia Gravis Quality-of-Life questionnaire.
Raggi A; Leonardi M; Ayadi R; Antozzi C; Maggi L; Baggi F; Mantegazza R
Muscle Nerve; 2017 Oct; 56(4):716-720. PubMed ID: 28029697
[TBL] [Abstract][Full Text] [Related]
3. Translation and validation of the arabic version of the myasthenia gravis activities of daily living scale.
Alanazy MH; Abuzinadah AR; Muayqil T
Muscle Nerve; 2019 May; 59(5):583-586. PubMed ID: 30697753
[TBL] [Abstract][Full Text] [Related]
4. Translation and validation of the arabic version of the revised 15-item myasthenia gravis quality-of-life questionnaire.
Alanazy MH; Abuzinadah AR; Muayqil T
Muscle Nerve; 2018 Apr; 57(4):581-585. PubMed ID: 28857210
[TBL] [Abstract][Full Text] [Related]
5. Reliability and Validity of Turkish Myasthenia Gravis-Activities of Daily Living Scale.
Karanfil E; Salcı Y; Fil-Balkan A; Bekircan-Kurt CE; Erdem Özdamar S; Armutlu K
OTJR (Thorofare N J); 2021 Apr; 41(2):101-107. PubMed ID: 33016212
[TBL] [Abstract][Full Text] [Related]
6. Physician- and self-assessed myasthenia gravis activities of daily living score.
Lee HL; Min JH; Seok JM; Cho EB; Cho HJ; Kim YD; Kim BJ
Muscle Nerve; 2018 Mar; 57(3):419-422. PubMed ID: 28796382
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).
Pasqualin F; Barnett C; Guidoni SV; Albertini E; Ermani M; Bonifati DM
Neurol Sci; 2022 Mar; 43(3):2059-2064. PubMed ID: 34505205
[TBL] [Abstract][Full Text] [Related]
8. The myasthenia gravis--specific activities of daily living profile.
Muppidi S
Ann N Y Acad Sci; 2012 Dec; 1274():114-9. PubMed ID: 23252905
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Besta Neurological Institute rating scale for myasthenia gravis.
Antozzi C; Brenna G; Baggi F; Camera G; Maggi L; Rezzani C; Montomoli C; Mantegazza R
Muscle Nerve; 2016 Jan; 53(1):32-7. PubMed ID: 26372817
[TBL] [Abstract][Full Text] [Related]
10. The Myasthenia Gravis-specific Activities of Daily Living scale as a useful outcome measure and in routine clinical management in Polish patients.
Rozmilowska IM; Adamczyk-Sowa MH; Czyzewski D
Neurol Neurochir Pol; 2018; 52(3):368-373. PubMed ID: 29370887
[TBL] [Abstract][Full Text] [Related]
11. Translation and validation of the Myasthenia Gravis Activities of Daily Living Questionnaire: Latvian version.
Grosmane A; Roze I; Roddate M; Ķauķe G; Žukova V; Glāzere I; Zolovs M; Ķēniņa V
Front Neurol; 2024; 15():1397603. PubMed ID: 38859974
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of outcome measures for myasthenia gravis subgroups.
Luo Y; Dong X; Peng Y; Cui B; Yan C; Jin W; Li Y; Zhou R; Huang K; Yang H
J Clin Neurosci; 2021 Sep; 91():270-275. PubMed ID: 34373039
[TBL] [Abstract][Full Text] [Related]
13. Validation of myasthenia gravis activity of daily living questionnaire: Persian version.
Faghani S; Okhvat AA; Karimi N; Moassefi M; Maroufi SF; Nafissi S; Fatehi F
Curr J Neurol; 2022 Jan; 21(1):35-39. PubMed ID: 38011442
[No Abstract] [Full Text] [Related]
14. MG-ADL: still a relevant outcome measure.
Muppidi S; Wolfe GI; Conaway M; Burns TM;
Muscle Nerve; 2011 Nov; 44(5):727-31. PubMed ID: 22006686
[TBL] [Abstract][Full Text] [Related]
15. Translation, cross-cultural adaptation, and validation of the french version of the 15-item Myasthenia Gravis Quality Of life scale.
Birnbaum S; Ghout I; Demeret S; Bolgert F; Eymard B; Sharshar T; Portero P; Hogrel JY
Muscle Nerve; 2017 May; 55(5):639-645. PubMed ID: 27533497
[TBL] [Abstract][Full Text] [Related]
16. Translation and validation of the 15-item Myasthenia Gravis Quality of life scale in Dutch.
Strijbos E; Gärtner FR; Verschuuren JJ
Muscle Nerve; 2018 Feb; 57(2):206-211. PubMed ID: 28271514
[TBL] [Abstract][Full Text] [Related]
17. Validation of the MG-DIS: a disability assessment for myasthenia gravis.
Raggi A; Leonardi M; Schiavolin S; Antozzi C; Brenna G; Maggi L; Mantegazza R
J Neurol; 2016 May; 263(5):871-882. PubMed ID: 26931109
[TBL] [Abstract][Full Text] [Related]
18. [Foot and ankle ability measure: cross-cultural translation and validation of the Italian version of the ADL module (FAAM-I/ADL)].
Sartorio F; Vercelli S; Bravini E; Bargeri S; Moroso M; Plebani G; Ferriero G
Med Lav; 2014 Jul; 105(5):357-65. PubMed ID: 25134631
[TBL] [Abstract][Full Text] [Related]
19. QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis.
Howard JF; Freimer M; O'Brien F; Wang JJ; Collins SR; Kissel JT;
Muscle Nerve; 2017 Aug; 56(2):328-330. PubMed ID: 28010051
[TBL] [Abstract][Full Text] [Related]
20. Validation of an Italian version of the functional index for hand osteoarthritis (FIHOA).
Gandini F; Giannitti C; Fattore G; Giordano N; Galeazzi M; Fioravanti A
Mod Rheumatol; 2012 Sep; 22(5):758-65. PubMed ID: 22245976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
